| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Sep 01, 2016 |
|||||||||
| Q3 FY16 | $0.29 | $0.28 | $3.79B | $3.61B |
NASDAQ |
||||
|
Campbell Soup
CPB
|
Q4 FY16 | $0.46 | $0.50 | $1.69B | $1.83B |
NASDAQ |
|||
|
Ciena Corporation
CIEN
|
Q3 FY16 | $0.42 | $0.38 | $670.55M | $606.73M |
NYSE |
|||
|
Genesco
GCO
|
Q2 FY17 | $0.34 | $0.26 | $625.56M | $515.20M |
NYSE |
|||
|
The Cooper Companies
COO
|
Q3 FY16 | $0.57 | $0.57 | $514.73M | $512.46M |
NASDAQ |
|||
|
Paymentus Holdings
PAY
|
- | -$0.28 | - | $488.10M | - |
NYSE |
|||
|
Methode Electronics
MEI
|
Q1 FY17 | $0.57 | $0.53 | $191.90M | $178.43M |
NYSE |
|||
|
Smith & Wesson Brands
SWBI
|
Q1 FY17 | $0.62 | $0.53 | $206.95M | $171.81M |
NASDAQ |
|||
|
Vera Bradley
VRA
|
Q2 FY17 | $0.17 | $0.13 | $119.25M | $110.69M |
NASDAQ |
|||
|
Lands' End
LE
|
Q2 FY16 | -$0.06 | -$0.01 | $292.01M | $97.34M |
NASDAQ |
|||
|
Ambarella
AMBA
|
Q2 FY17 | $0.54 | $0.37 | $65.14M | $45.81M |
NASDAQ |
|||
|
Aytu BioPharma
AYTU
|
- | -$181.60 K | -$62.40 K | $937.31K | - |
NASDAQ |
|||
|
Indaptus Therapeutics
INDP
|
- | -$30.40 | -$29.60 | - | - |
NASDAQ |
|||
|
Quoin Pharmaceuticals
QNRX
|
- | - | - | - | - |
NASDAQ |
|||
| Show 4 more companies | |||||||||
